Alan Roemer has served as Senior Vice President, Corporate Development of Roivant Sciences, Inc. since July 2016. He is a founding leadership team member and previously served as Roivant’s Senior Vice President, Finance & Operations from the company’s inception through June 2016 and Chief Financial Officer of Axovant Sciences, Inc. in 2015. From 2009 to 2014, Mr. Roemer was a Managing Director for the Trout Group and Trout Capital, where he provided financing, strategic advisory and investor relations services for life sciences clients. He previously served as Chief Financial Officer & Treasurer of Zelos Therapeutics Inc. and was a Vice President at Pharmasset, Inc. (acquired by Gilead) from 1999 to 2008. Prior to Pharmasset, Mr. Roemer was a healthcare consultant for Booz-Allen & Hamilton and Deloitte Consulting, and he held various operational roles at Bank of America. He is a director of NexImmune, Inc. and a trustee of the Helene Fuld College of Nursing. Mr. Roemer received his B.S. in Business Administration from Georgetown University and his M.B.A. and M.P.H. degrees from Emory University’s Goizueta Business School and Rollins School of Public Health.

 Business Administration & Management